Global Feature
2013: The Year Ahead
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
As a new year begins, what may be on the horizon for 2013 for biopharmaceutical/pharmaceutical companies and their suppliers? A look ahead into what issues are shaping the industry.
Biologics
Venture Capital Stays Strong in Biotech Financing
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management.
Financing from initial public offerings and and global mergers and acquisitions were down in 2012 and venture-capital funding stayed strong.
Outsourcing
Acquisitions Reshape the Bio/Pharm Services Industry
Jim Miller, president of PharmSource Information Services
The quest to build critical mass and broaden capabilities has been a key factor in dealmaking.

Pharma Industry's Global Health and Sustainability Forum
Pharma News in Global Health and Sustainability
A roundup of developments in global health and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

GlaxoSmithKline Uses Mobile Technology to Advance Vaccinations
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management GlaxoSmithKline partners with the mobile telecommunications company Vodafone to tackle common infectious diseases in Africa.

|